Matthew T Wittbrodt1, Nil Z Gurel, Jonathon A Nye, Md Mobashir H Shandhi, Asim H Gazi, Amit J Shah, Bradley D Pearce, Nancy Murrah, Yi-An Ko, Lucy H Shallenberger, Viola Vaccarino, Omer T Inan, J Douglas Bremner. 1. From the Department of Psychiatry and Behavioral Sciences (Wittbrodt, Bremner), Emory University School of Medicine; School of Electrical and Computer Engineering (Gurel, Shandhi, Gazi, Inan), Georgia Institute of Technology; Department of Radiology (Nye) and Imaging Sciences, Emory University School of Medicine; Department of Epidemiology (Shah, Pearce, Murrah, Shallenberger, Vaccarino), Rollins School of Public Health, Emory University; Division of Cardiology, Department of Medicine (Shah, Vaccarino), Emory University School of Medicine, Atlanta; Atlanta VA Medical Center (Shah, Bremner), Decatur; Department of Biostatistics and Bioinformatics, Rollins School of Public Health (Ko), Emory University; and Wallace H. Coulter Department of Biomedical Engineering (Inan), Georgia Institute of Technology, Atlanta, Georgia.
Abstract
OBJECTIVE: Posttraumatic stress disorder (PTSD) is a disabling condition affecting a large segment of the population; however, current treatment options have limitations. New interventions that target the neurobiological alterations underlying symptoms of PTSD could be highly beneficial. Transcutaneous cervical (neck) vagal nerve stimulation (tcVNS) has the potential to represent such an intervention. The goal of this study was to determine the effects of tcVNS on neural responses to reminders of traumatic stress in PTSD. METHODS: Twenty-two participants were randomized to receive either sham (n = 11) or active (n = 11) tcVNS stimulation in conjunction with exposure to neutral and personalized traumatic stress scripts with high-resolution positron emission tomography scanning with radiolabeled water for brain blood flow measurements. RESULTS: Compared with sham, tcVNS increased brain activations during trauma scripts (p < .005) within the bilateral frontal and temporal lobes, left hippocampus, posterior cingulate, and anterior cingulate (dorsal and pregenual), and right postcentral gyrus. Greater deactivations (p < .005) with tcVNS were observed within the bilateral frontal and parietal lobes and left thalamus. Compared with tcVNS, sham elicited greater activations (p < .005) in the bilateral frontal lobe, left precentral gyrus, precuneus, and thalamus, and right temporal and parietal lobes, hippocampus, insula, and posterior cingulate. Greater (p < .005) deactivations were observed with sham in the right temporal lobe, posterior cingulate, hippocampus, left anterior cingulate, and bilateral cerebellum. CONCLUSIONS: tcVNS increased anterior cingulate and hippocampus activation during trauma scripts, potentially indicating a reversal of neurobiological changes with PTSD consistent with improved autonomic control.Trial Registration: No. NCT02992899.
OBJECTIVE: Posttraumatic stress disorder (PTSD) is a disabling condition affecting a large segment of the population; however, current treatment options have limitations. New interventions that target the neurobiological alterations underlying symptoms of PTSD could be highly beneficial. Transcutaneous cervical (neck) vagal nerve stimulation (tcVNS) has the potential to represent such an intervention. The goal of this study was to determine the effects of tcVNS on neural responses to reminders of traumatic stress in PTSD. METHODS: Twenty-two participants were randomized to receive either sham (n = 11) or active (n = 11) tcVNS stimulation in conjunction with exposure to neutral and personalized traumatic stress scripts with high-resolution positron emission tomography scanning with radiolabeled water for brain blood flow measurements. RESULTS: Compared with sham, tcVNS increased brain activations during trauma scripts (p < .005) within the bilateral frontal and temporal lobes, left hippocampus, posterior cingulate, and anterior cingulate (dorsal and pregenual), and right postcentral gyrus. Greater deactivations (p < .005) with tcVNS were observed within the bilateral frontal and parietal lobes and left thalamus. Compared with tcVNS, sham elicited greater activations (p < .005) in the bilateral frontal lobe, left precentral gyrus, precuneus, and thalamus, and right temporal and parietal lobes, hippocampus, insula, and posterior cingulate. Greater (p < .005) deactivations were observed with sham in the right temporal lobe, posterior cingulate, hippocampus, left anterior cingulate, and bilateral cerebellum. CONCLUSIONS: tcVNS increased anterior cingulate and hippocampus activation during trauma scripts, potentially indicating a reversal of neurobiological changes with PTSD consistent with improved autonomic control.Trial Registration: No. NCT02992899.
Authors: Lisa M Shin; George Bush; Paul J Whalen; Kathryn Handwerger; Paul A Cannistraro; Christopher I Wright; Brian Martis; Michael L Macklin; Natasha B Lasko; Scott P Orr; Roger K Pitman; Scott L Rauch Journal: J Trauma Stress Date: 2007-10
Authors: Anke Karl; Michael Schaefer; Loretta S Malta; Denise Dörfel; Nicolas Rohleder; Annett Werner Journal: Neurosci Biobehav Rev Date: 2006-05-26 Impact factor: 8.989
Authors: Matthew T Wittbrodt; Kasra Moazzami; Bruno B Lima; Zuhayr S Alam; Daniel Corry; Muhammad Hammadah; Carolina Campanella; Laura Ward; Arshed A Quyyumi; Amit J Shah; Viola Vaccarino; Jonathon A Nye; J Douglas Bremner Journal: J Affect Disord Date: 2019-05-11 Impact factor: 4.839
Authors: Nil Z Gurel; Matthew T Wittbrodt; Hewon Jung; Stacy L Ladd; Amit J Shah; Viola Vaccarino; J Douglas Bremner; Omer T Inan Journal: IEEE J Biomed Health Inform Date: 2020-03-16 Impact factor: 5.772
Authors: Asim H Gazi; Matthew T Wittbrodt; Anna B Harrison; Srirakshaa Sundararaj; Nil Z Gurel; Jonathon A Nye; Amit J Shah; Viola Vaccarino; J Douglas Bremner; Omer T Inan Journal: IEEE Trans Biomed Eng Date: 2022-01-20 Impact factor: 4.538